Regine Brandt1, Robert Grützmann, Andrea Bauer
1Department of Medicine II, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. This review compares microarray data to identify novel molecular markers for earlier diagnosis and improved treatment of this pancreatic cancer.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: